Media

News

Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.

 

Canadian Students Receive $90,000 in Support from Bayer Fund’s Opportunity Scholarship
Bayer launches Proline® GOLD for premium protection against sclerotinia in canola
Bayer to acquire UK-based biotech KaNDy Therapeutics Ltd.
Bayer to acquire UK-based biotech KaNDy Therapeutics Ltd.
Bayer’s finerenone meets primary endpoint in Phase III FIDELIO-DKD renal outcomes study in patients with chronic kidney disease and type 2 diabetes
Bayer Inc. launches FastTRK, a complimentary clinical testing program for the diagnosis of NTRK gene fusions in TRK fusion cancer patients in Canada
Bayer announces agreements to resolve major legacy Monsanto litigation
Non-metastatic castration resistant prostate cancer treatment NUBEQA® (darolutamide) significantly improves overall survival with a favourable safety profile in men with non-metastatic prostate cancer